Open-label, Single-center, Non-randomized, Phase I, Dose-ranging Study of Endoscopic Ultrasound (EUS) Guided Photodynamic Therapy (PDT) With Photofrin in Locally Advanced Pancreatic Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Porfimer sodium (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions
- 28 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated
- 09 Apr 2017 Planned End Date changed from 1 Jan 2018 to 31 Jan 2020.